VistaGen Therapeutics's Stock Price And Volume Action
VistaGen Therapeutics's VTGN stock is trading up 7.9% to a price of $2.33. Thursday the stock has been traded at a volume of 762.60 thousand, about 16.32% of its recent 30-day volume average of 4.67 million.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: VistaGen Therapeutics shares are trading higher after the company announced its PH10 nasal spray showed a different mechanism of action from benzodiazepines in a preclinical study.
Further Analysis of Recent Price Action
The stock's 50-day moving average was $2.18 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $3.18 and fallen to a low of $0.3.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.